Prell H H, Auer J, Soska J
Mol Gen Genet. 1984;198(2):110-5. doi: 10.1007/BF00328709.
The effects were studied of three clear plaque mutations of phage P22 (cir4-1, cir5-1 and cir6-1) on antirepressor synthesis. The mutant site cir4-1 has no influence on the expression of gene ant. The cir5-1 and cir6-1 mutations prevent the repression of early ant synthesis shortly after infection: P22 cir5-1 exhibits a strong ant-overproduction because it renders the cir5 repressor protein defective for turning off early ant expression (Harvey et al. 1981). P22 cir6-1 exhibits only a low level of constitutive ant synthesis insensitive to cir5-directed repression. Complementation experiments between P22 wild type or mutant in the cir5 or cir6 sites reveal the following phenotypes of the cir6-1 mutation: (1) The cir6-1 site behaves as a weak promotor site insensitive to cir5-directed repression of ant synthesis. (2) In the P22 cir5-1 cir6-1 double recombinant the cir6-1 site is cis dominant preventing ant overproduction as observed in simple P22 cir5-1 infections. (3) Some of the deficient phenotypes of P22 cir6-1 can be complemented by co-infecting P22 mutants carrying a cir6+ allele. These results are explained by the following model: The active cir5 repressor protein is a dimer (or oligomer) and the cir5-1 and cir6-1 mutations map in different domains influencing the repressing as well as the dimer forming activities of this protein. Which particular cir6-1 phenotype is observed depends on the experimental conditions employed, and on the promotor site (either pANT or cir6-1) from which ant expression procedes.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了噬菌体P22的三种清晰噬菌斑突变(cir4-1、cir5-1和cir6-1)对抗阻遏物合成的影响。突变位点cir4-1对基因ant的表达没有影响。cir5-1和cir6-1突变在感染后不久阻止早期ant合成的抑制:P22 cir5-1表现出强烈的ant过量产生,因为它使cir5阻遏蛋白在关闭早期ant表达方面存在缺陷(哈维等人,1981年)。P22 cir6-1仅表现出低水平的组成型ant合成,对cir5介导的抑制不敏感。cir5或cir6位点的P22野生型或突变体之间的互补实验揭示了cir6-1突变的以下表型:(1)cir6-1位点表现为一个弱启动子位点,对cir5介导的ant合成抑制不敏感。(2)在P22 cir5-1 cir6-1双重组体中,cir6-1位点是顺式显性的,可防止像在简单的P22 cir5-1感染中观察到的ant过量产生。(3)P22 cir6-1的一些缺陷表型可通过共感染携带cir6+等位基因的P22突变体得到互补。这些结果由以下模型解释:活性cir5阻遏蛋白是二聚体(或寡聚体),cir5-1和cir6-1突变位于不同结构域,影响该蛋白的抑制活性以及二聚体形成活性。观察到哪种特定的cir6-1表型取决于所采用的实验条件以及ant表达起始的启动子位点(要么是pANT,要么是cir6-1)。(摘要截短于250字)